WKSWA
PFE icon

White Knight Strategic Wealth Advisors’s Pfizer PFE Stock Holding History

White Knight Strategic Wealth Advisors’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$553K Buy
22,957
+3,442
+18% +$90K 0.39% 51
2026
Q1 		$548K Sell
19,515
-5,521
-22% -$147K 0.46% 48
2025
Q4 		$623K Buy
25,036
+10,174
+68% +$257K 0.46% 50
2025
Q3 		$379K Buy
14,862
+485
+3% +$12K 0.3% 58
2025
Q2 		$348K Buy
14,377
+4,980
+53% +$116K 0.3% 61
2025
Q1 		$238K Sell
9,397
-13,757
-59% -$360K 0.22% 74
2024
Q4 		$614K Buy
23,154
+7,772
+51% +$211K 0.26% 63
2024
Q3 		$445K Hold
15,382
– – 0.4% 50
2024
Q2 		$430K Buy
15,382
+1,902
+14% +$52.4K 0.43% 44
2024
Q1 		$374K Buy
13,480
+4
+0% +$111 0.39% 50
2023
Q4 		$388K Sell
13,476
-7,052
-34% -$213K 0.45% 46
2023
Q3 		$681K Buy
20,528
+604
+3% +$21.4K 0.9% 26
2023
Q2 		$731K Buy
19,924
+2,781
+16% +$108K 0.86% 28
2023
Q1 		$699K Buy
17,143
+4,385
+34% +$189K 0.88% 28
2022
Q4 		$654K Sell
12,758
-488
-4% -$23.4K 0.9% 30
2022
Q3 		$580K Buy
+13,246
New +$644K 0.83% 31

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

White Knight Strategic Wealth Advisors's PFE Position: Q2 2026 in Review

White Knight Strategic Wealth Advisors increased its Pfizer (PFE) stake by 18% in Q2 2026, buying an estimated $90K and bringing the position to 22,957 shares worth $553K. The position accounts for 0.39% of the portfolio, ranked #51.

White Knight Strategic Wealth Advisors first reported a position in PFE in Q3 2022 and has held it in 16 quarters since. The position peaked at $731K in Q2 2023. 2,834 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • White Knight Strategic Wealth Advisors held 22,957 shares of Pfizer worth $553K as of Q2 2026.
  • White Knight Strategic Wealth Advisors bought 3,442 Pfizer shares in Q2 2026, an estimated $90K.
  • Pfizer made up 0.39% of White Knight Strategic Wealth Advisors's portfolio in Q2 2026, its #51 holding.
  • White Knight Strategic Wealth Advisors first reported a position in Pfizer in Q3 2022 and has held it in 16 quarters since.
  • White Knight Strategic Wealth Advisors's Pfizer position peaked at $731K in Q2 2023.
  • 2,834 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on White Knight Strategic Wealth Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.